Hypertrophic cardiomyopathy: Difference between revisions
mNo edit summary |
mNo edit summary |
||
| Line 44: | Line 44: | ||
==Special Patient Populations== | ==Special Patient Populations== | ||
[[Hypertrophic cardiomyopathy in special clinical scenarios#Management of HCM in presence of hypotension and cardiovascular collapse|Hypotension/Cardiovascular collapse]] | [[Hypertrophic cardiomyopathy in special clinical scenarios#Management of the HCM Patient During Pregnancy|Pregnancy]] | [[Hypertrophic cardiomyopathy in special clinical scenarios#Management of HCM in presence of hypotension and cardiovascular collapse|Hypotension/Cardiovascular collapse]] | [[Hypertrophic cardiomyopathy in special clinical scenarios#Management of the HCM Patient During Pregnancy|Pregnancy]] | ||
==2011 ACCF/AHA Guideline Recommendations== | |||
[[Hypertrophic cardiomyopathy screening|Genetic Testing Strategies/Family Screening]] | [[Hypertrophic cardiomyopathy genetics|Genotype-Positive/Phenotype-Negative Patients]] | | |||
==Guideline Resources== | ==Guideline Resources== | ||
Revision as of 15:19, 22 December 2011
For patient information click here
| Hypertrophic cardiomyopathy | |
 | |
|---|---|
| Hypertrophic cardiomyopathy. Image courtesy of Professor Peter Anderson DVM PhD and published with permission © PEIR, University of Alabama at Birmingham, Department of Pathology | |
| ICD-10 | I42.1-I42.2 |
| ICD-9 | 425.4 |
| DiseasesDB | 6373 |
| MeSH | D002312 |
|
Hypertrophic Cardiomyopathy Microchapters |
|
Differentiating Hypertrophic Cardiomyopathy from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Hypertrophic cardiomyopathy On the Web |
|
Directions to Hospitals Treating Hypertrophic cardiomyopathy |
|
Risk calculators and risk factors for Hypertrophic cardiomyopathy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and Related Terms: Hypertrophic cardiomyopathy or HCM, Asymmetric septal hypertrophy or ASH, Hypertrophic obstructive cardiomyopathy, HOCM, Idiopathic hypertrophic subaortic stenosis or IHSS, familial isolated hypertrophic obstructive cardiomyopathy, familial isolated hypertrophic subaortic stenosis, familial or idiopathic hypertrophic subaortic stenosis, familial or idiopathic hypertrophic obstructive cardiomyopathy, primitive hypertrophic obstructive cardiomyopathy, primitive hypertrophic subaortic stenosis, muscular subaortic stenosis, apical hypertrophic cardiomyopathy, which is also known as nonobstructive hypertrophic cardiomyopathy and Japanese variant hypertrophic cardiomyopathy or the Yamaguchi variant (since the first cases described were all in individuals of Japanese descent).
Overview
Pathophysiology
Genetics | Histopathologic Abnormalities | Anatomic Abnormalities | Outflow Obstruction | Ischemia | Arrhythmogenesis
Epidemiology and Demographcis
Screening
Differential Diagnosis
Natural History, Prognosis and Sudden Cardiac Death Risk
Diagnosis
History and Symptoms | Physical examination | Electrocardiogram | Echocardiography | Cardiac MRI | Cardiac CT | Positron Emission Tomography | Cardiac Catheterization | Electrophysiologic study | Pathological Findings
Treatment
Medical treatment | Interventional Cardiology and Device Based Therapy | Surgical treatment | Treatment strategy
Special Patient Populations
Hypotension/Cardiovascular collapse | Pregnancy
2011 ACCF/AHA Guideline Recommendations
Genetic Testing Strategies/Family Screening | Genotype-Positive/Phenotype-Negative Patients |
Guideline Resources
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy [1][2]
External links
- Hypertrophic Cardiomyopathy Association
- Cardiomyopathy Association
- Hypertrophic Cardiomyopathy Research Foundation
References
- ↑ Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW (2011). "2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy: Executive Summary A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Journal of the American College of Cardiology. 58 (25): 2703–38. doi:10.1016/j.jacc.2011.10.825. PMID 22075468. Retrieved 2011-12-19. Unknown parameter
|month=ignored (help) - ↑ Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, Naidu SS, Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE, Yancy CW (2011). "2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the American Association for Thoracic Surgery, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons". Journal of the American College of Cardiology. 58 (25): e212–60. doi:10.1016/j.jacc.2011.06.011. PMID 22075469. Retrieved 2011-12-19. Unknown parameter
|month=ignored (help)